Validation of a fibrinogen γ' enzyme-linked immunosorbent assay using a new monoclonal antibody: effects of bariatric surgery.

Res Pract Thromb Haemost · 2024 · PMC10876905 · PMID 38379712

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantP = .06so close (0.05 < p ≤ 0.1)

However, results were confirmed in medication-free patients, although the reduction in fibrinogen γ’ was only borderline significant ( P = .06).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.